Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts. Show more
Location: 11 Huron Drive, Natick, MA, 01760, United States | Website: https://www.allurion.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
21.18M
52 Wk Range
$2.15 - $25.75
Previous Close
$2.99
Open
$2.95
Volume
179,939
Day Range
$2.80 - $2.95
Enterprise Value
80.69M
Cash
20.41M
Avg Qtr Burn
-10.78M
Insider Ownership
11.67%
Institutional Own.
46.24%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|